7.1 Non-Pharmacologic Therapies, Cardiac Nutrition & Exercise

7.1 Non-Pharmacologic Therapies, Cardiac Nutrition & Exercise

[!NOTE] ANCC Blueprint Focus: Domain II (Planning and Implementation) tests the cardiovascular nurse's proficiency in designing, tailoring, and evaluating non-pharmacologic interventions. Candidates are expected to master dietary sodium and fluid restrictions across various stages of heart failure, exercise prescription nuances under beta-blocker therapy, contraindications to smoking cessation pharmacotherapies, and evidence-based stress reduction strategies.

Non-pharmacologic lifestyle modifications represent the foundational bedrock of cardiovascular disease prevention and chronic disease management. When combined with guideline-directed medical therapy (GDMT), structured lifestyle interventions substantially attenuate atherosclerotic progression, enhance myocardial efficiency, improve functional capacity, and reduce hospital readmissions.

---

Evidence-Based Cardiac Nutrition

Dietary interventions exert profound effects on endothelial function, vascular tone, lipid atherogenicity, and systemic inflammatory cascades. The cardiovascular nurse must guide patients through specific, evidence-based nutritional frameworks tailored to their underlying pathophysiology.

Clinical Nuances of Sodium & Fluid Management in Heart Failure

• The Pitfall of Excessive Sodium Restriction: While contemporary guidelines advocate for <2,000 mg/day of sodium in symptomatic heart failure, rigid or extreme restriction (<1,500 mg/day) is no longer recommended. Clinical trials (such as SODIUM-HF) demonstrate that severe sodium restriction does not reduce clinical events and may paradoxically stimulate the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS). This neurohormonal overactivation induces renal efferent arteriolar constriction, worsens prerenal azotemia, and triggers neurohormonal maladaptation.
• Indications for Fluid Restriction: Routine fluid restriction is not indicated for all heart failure patients. It is strictly reserved for two specific patient cohorts:
  1. Patients with refractory, advanced heart failure (Stage D or NYHA Class IV) experiencing persistent fluid overload despite escalating diuretic regimens.
  2. Patients presenting with significant hypervolemic (dilutional) hyponatremia, defined as a serum sodium level <130 mEq/L in the presence of physical signs of systemic congestion.
• Bedside Nursing Surveillance & Self-Monitoring Rules:
  • Weigh daily immediately upon waking, after first morning void, before eating breakfast, wearing consistent clothing, and on the same calibrated scale.
  • Maintain an ongoing weight log and recognize the 'Rule of 2 and 5': notify the cardiology care team if weight increases by ≥2 to 3 lbs (0.9 to 1.4 kg) in 24 hours or ≥5 lbs (2.3 kg) in one single week.
  • Teach patients to account for all liquid-at-room-temperature foods (ice chips count as half their frozen volume in water, gelatin, broths, and ice creams).

---

Structured Exercise Prescription & Hemodynamic Principles

Exercise prescription in cardiovascular nursing is structured according to the FITT-VP framework: Frequency, Intensity, Time, Type, Volume, and Progression.

Exercise Prescription Parameters (AHA/ACSM Guidelines)

• Aerobic Conditioning:
  • Frequency: At least 3 to 5 days per week, ideally accumulated on most days of the week.
  • Time / Duration: 30 to 60 minutes per session (accumulating ≥150 minutes/week of moderate-intensity or ≥75 minutes/week of vigorous-intensity aerobic physical activity).
  • Type: Large muscle group, rhythmic, dynamic activities such as brisk walking, cycling, arm ergometry, or aquatic exercise.
• Resistance Training:
  • Frequency: 2 to 3 non-consecutive days per week.
  • Volume & Intensity: 8 to 10 distinct exercises targeting major muscle groups; 1 to 3 sets of 10 to 15 repetitions per exercise at 40% to 60% of 1-Repetition Maximum (1-RM).
  • Clinical Safety Rule: Patients must strictly avoid the Valsalva maneuver (forced expiration against a closed glottis during lifting). The Valsalva maneuver induces acute spikes in intrathoracic pressure, dramatically increases left ventricular afterload, impairs coronary perfusion, and triggers severe baroreceptor-mediated bradycardia upon release.

Determining Exercise Intensity: Heart Rate vs. Borg RPE Scale

Under normal physiological conditions, target heart rate is calculated via the Karvonen Formula (Heart Rate Reserve [HRR] method):

$\text{Target Heart Rate (THR)} = [(\text{HR}_{\max} - \text{HR}_{\text{rest}}) \times \%\,\text{Target Intensity}] + \text{HR}_{\text{rest}}$

Where moderate intensity is defined as 40% to 59% HRR and vigorous intensity is 60% to 80% HRR.

[!IMPORTANT] The Beta-Blocker Chronotropic Blunting Effect: Beta-adrenergic antagonists (e.g., carvedilol, metoprolol succinate, bisoprolol) competitively inhibit myocardial $\beta_1$-adrenergic receptors, blunting SA nodal automaticity and preventing heart rate from rising proportionally to workload. In patients receiving chronic beta-blocker therapy, target heart rate formulas are clinically invalid and unsafe.

In these patients, the cardiovascular nurse must utilize the Borg Rating of Perceived Exertion (RPE) scale (6 to 20 Category Scale). Target exercise intensity should be maintained between 11 and 14 ('fairly light' to 'somewhat hard'), which correlates closely with the ventilatory threshold and safe aerobic conditioning without precipitating myocardial ischemia or anaerobic lactate accumulation.

Exercise Termination (Safety Stopping) Criteria

Nurses must immediately terminate an exercise session and evaluate the patient upon observing any of the following clinical red flags:

1. A drop in systolic blood pressure of >10 mmHg below baseline despite an increase in workload, accompanied by evidence of hypoperfusion.
2. Excessive hypertensive response: Systolic blood pressure >220 mmHg or diastolic blood pressure >110 mmHg.
3. Development of classic angina pectoris, ischemic chest tightness, or neck/jaw/arm radiation.
4. Central nervous system symptoms: Dizziness, presyncope, ataxia, pallor, cold clammy diaphoresis, or confusion.
5. Electrocardiographic abnormalities: Onset of sustained supraventricular tachycardia, ventricular tachycardia, frequent premature ventricular contractions (>6/min or multifocal), or horizontal/downsloping ST-segment depression >2 mm.

---

Smoking Cessation Pharmacotherapy & Behavioral Counseling

Tobacco smoking is the leading preventable cause of cardiovascular mortality worldwide. Cessation yields an immediate ~50% reduction in secondary myocardial infarction risk within 1 year, and cardiovascular mortality drops to near that of a non-smoker within 5 to 15 years.

The 5 A's Behavioral Counseling Model

Every clinical encounter must incorporate the evidence-based 5 A's framework:

1. Ask: Systematically identify and document tobacco use status at every clinical visit.
2. Advise: Urge every tobacco user to quit in a clear, strong, and personalized manner (linking cessation directly to their specific cardiac diagnosis, such as stent patency or graft survival).
3. Assess: Determine willingness to make a quit attempt within the next 30 days using motivational interviewing techniques.
4. Assist: Aid the patient in formulating a structured quit plan (setting a quit date within 2 weeks, removing tobacco from home/work, enlisting family support, anticipating withdrawal cravings).
5. Arrange: Schedule follow-up contact (telephone check-in within the first week after the quit date and a clinical visit within the first month).

First-Line Smoking Cessation Pharmacotherapy

---

Stress Reduction Techniques & Psychosocial Management

Psychosocial distress (depression, generalized anxiety, chronic socioeconomic strain, and Type D personality patterns characterized by negative affectivity and social inhibition) directly triggers autonomic nervous system imbalance:

• Pathophysiological Axis: Chronic stress stimulates the Hypothalamic-Pituitary-Adrenal (HPA) axis, triggering excessive cortisol secretion, sustained sympathetic nervous system hyperarousal, endothelial dysfunction, accelerated coronary atherogenesis, and platelet hyperreactivity.
• Mindfulness-Based Stress Reduction (MBSR): Incorporates mindful body scanning, gentle stretching, and cognitive centering. Proven to lower resting blood pressure, augment vagal tone, and increase heart rate variability (HRV), a direct biomarker of parasympathetic resilience.
• Cognitive Behavioral Therapy (CBT): Identifies and restructures maladaptive cognitive distortions (catastrophizing, external locus of control), directly decreasing the incidence of post-infarction depression and improving adherence to cardiac regimens.
• The Benson Relaxation Response & Diaphragmatic Breathing: Slow, rhythmic diaphragmatic breathing targeting 5 to 6 breaths per minute activates baroreflex sensitivity, stimulates pulmonary stretch receptors, drives central parasympathetic efferent outflow, and blunts peripheral vascular tone, yielding immediate reductions in systemic vascular resistance.

---

Complementary and Integrative Therapies

The ANCC blueprint pairs non-pharmacologic with complementary therapies, so the exam expects you to counsel on integrative practices without either dismissing them or endorsing them beyond the evidence. Complementary means used alongside conventional care; alternative means used instead of it, and the nurse's role is to keep patients out of the second category.

Mind-Body and Movement Practices

• Yoga, tai chi, and qigong: Low-to-moderate-intensity movement with breath control. Small trials show modest reductions in blood pressure and improved quality of life and balance in heart failure and post-infarction patients. They are reasonable adjuncts to — never substitutes for — a supervised cardiac rehabilitation exercise prescription.
• Meditation and guided imagery: The AHA has issued a scientific statement concluding that meditation may be considered as an adjunct to guideline-directed therapy for cardiovascular risk reduction, with the caveat that the evidence base is small and heterogeneous.
• Acupuncture and massage: Sometimes used for angina-associated anxiety, post-sternotomy pain, or nausea. Screen for anticoagulation and thrombocytopenia before any needling or deep-tissue technique.

Supplements: What the Nurse Must Actually Ask

Ask about supplements at every medication reconciliation, because patients routinely omit them when asked what medications they take. Frame the question as "what vitamins, herbs, teas, or over-the-counter products do you take?"

[!CAUTION] The exam's recurring stem: a patient on warfarin, apixaban, or amiodarone who quietly started an herbal product. The correct nursing action is never to shame the patient or to order them to stop everything. It is to document the product, notify the prescriber, and arrange the appropriate monitoring (INR, symptom check, or drug level) — because the interaction, not the supplement itself, is what harms the patient.